Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Related Experiment Video
Updated: Oct 4, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
An Integrated, Multimodal, Digital Health Solution for Chronic Obstructive Pulmonary Disease: Prospective
Brian D Gelbman1, Carol R Reed2
1Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical Center, New York, NY, United States.
Patients with chronic obstructive pulmonary disease (COPD) successfully used the Wellinks mHealth platform for remote data collection. The study showed high patient engagement and satisfaction, indicating its value for COPD management.
Area of Science:
- Digital health applications
- Remote patient monitoring
- Chronic obstructive pulmonary disease (COPD) management
Background:
- COPD significantly impacts millions, leading to high healthcare costs via hospitalizations.
- Digital health enables remote data collection for chronic disease management, including COPD.
Purpose of the Study:
- To evaluate patient ability to use the Wellinks mHealth platform for collecting COPD-relevant data.
- To assess patient satisfaction and engagement with the mHealth platform.
Main Methods:
- Pilot study involving 19 adult COPD patients using the Wellinks platform for 8 weeks.
- Data collected via spirometer, pulse oximeter, and manual symptom/medication entry.
- Patient satisfaction assessed using surveys and Net Promoter Score (NPS).
Main Results:
- High correlation (r=0.94-0.96) between home and office spirometry measurements.
- High patient satisfaction (81% found app valuable, 94% found it easy to use) and NPS of 59.
- Consistent engagement with devices and app across varying COPD severity.
Conclusions:
- The Wellinks mHealth platform demonstrates feasibility and high patient engagement for COPD management.
- Patients of varying severity, age, and gender successfully utilized the technology.
- The platform supports timely clinical decision-making for improved COPD care.

